WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012104293) (1,2,4)TRIAZOLO[4,3-A]QUINOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/104293    International Application No.:    PCT/EP2012/051546
Publication Date: 09.08.2012 International Filing Date: 31.01.2012
IPC:
C07D 487/04 (2006.01), A61K 31/519 (2006.01), A61P 25/00 (2006.01)
Applicants: BOEHRINGER INGELHEIM INTERNATIONAL GmbH [DE/DE]; Binger Strasse 173 55216 Ingelheim am Rhein (DE) (For All Designated States Except US).
LANKAU, Hans-Joachim [DE/DE]; (DE) (For US Only).
LANGEN, Barbara [DE/DE]; (DE) (For US Only).
GRUNWALD, Christian [DE/DE]; (DE) (For US Only).
HÖFGEN, Norbert [DE/DE]; (DE) (For US Only).
STANGE, Hans [DE/DE]; (DE) (For US Only).
DOST, Rita [DE/DE]; (DE) (For US Only).
EGERLAND, Ute [DE/DE]; (DE) (For US Only)
Inventors: LANKAU, Hans-Joachim; (DE).
LANGEN, Barbara; (DE).
GRUNWALD, Christian; (DE).
HÖFGEN, Norbert; (DE).
STANGE, Hans; (DE).
DOST, Rita; (DE).
EGERLAND, Ute; (DE)
Agent: WEIß, Wolfgang; Weickmann & Weickmann Postfach 860 820 81635 München (DE)
Priority Data:
61/437,848 31.01.2011 US
Title (EN) (1,2,4)TRIAZOLO[4,3-A]QUINOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES
(FR) DÉRIVÉS DE (1,2,4)TRIAZOLO[4,3-A]QUINOXALINE UTILISÉS COMME INHIBITEURS DES PHOSPHODIESTÉRASES
Abstract: front page image
(EN)The invention relates to (1,2,4)triazolo[4,3-a]quinoxaline derivatives of Formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases.
(FR)L'invention concerne des dérivés de (1,2,4)triazolo[4,3-a]quinoxaline représentés par la formule (I) qui sont des inhibiteurs de la phosphodiestérase 2 et/ou 10, utilisés pour traiter les maladies du système nerveux central.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)